overview el hassan sefrioui, ph.d. hassan... · 2015-12-17 · el hassan sefrioui, ph.d. 1. mascir...
TRANSCRIPT
OVERVIEW
EL Hassan Sefrioui, Ph.D.
www.mascir.com
1
MASCIR
Moroccan Foundation for Advanced Science, Innovation and Research
MISSION
MAScIR performs scientific research in nanomaterials, microelectronic and
biotechnology. Combine competences & state-of-the-art platforms to deliver
industry-relevant technology solutions in agriculture, energy & healthcare.
GOVERNANCE & ORGANIZATION
Non profit foundation.
PRESIDENT
Ministre of Industry of Morocco
ABOUT MASCIR
2
Date of creation2007
Researchers & engineers
100
BOARD OF TRUSTEES
SCIENTIFIC BOARD
COMMITEES
ACHIEVEMENTS
3
Bre
ve
ts
Pu
blic
atio
ns
Co
ntr
ac
ts
1
7
13
24
30
0
5
10
15
20
25
30
35
2010 2011 2012 2013 2014
18
38
63
7883
0
20
40
60
80
100
2010 2011 2012 2013 2014
6
17
22 23
35
0
5
10
15
20
25
30
35
40
2010 2011 2012 2013 2014
4
PROJECTS
OUR PARTNERS
5
R&D PLATFORMS
Microelectronics
Nanotechnology
Biotechnology
6
7
MICROELECTRONICS (clean room grade 1000)
DOMAINS OF APPLICATIONS
AEROSPACE DEFENSE AUTOMOTIVE
8
9
NANOTECHNOLOGY (RMN, HPLC-MS-MS…)
DOMAINS OF EXPERTIZE & APPLICATIONS
VALORIZATION OF NATURAL RESOURCES (CLAY,
PHOSPHATES)RENEWABLE ENERGIES TEXTILE
10
MEDICAL BIOTECHNOLOGY (GLP, P3 room, ISO17025)
11
AREAS OF MARKET APPLIED RESEARCH
12
DEVELOPMENT OF DIAGNOSTIC KITS
DRUGS DEVELOPMENT AGRICULTURE
Lab completed in 2010
13
MEDICAL BIOTECHNOLOGY Center: PIPELINES
Field Indication State of art/Platformvalidation
LaboratoryPhase
ClinicalPhase
Market
In Vitro
Diagnostic
Kits
(Prototypes)
- Leukemia
- Breast cancer
-Tuberculosis
- Prostate cancer
Biosimilar
Medicines
(Prototypes)
- Anti-cancer
100% MAScIR
100% MAScIR
In collaboration: - School of Médicine, Rabat - ndustry Partner, Morocco
In collaboration: Institut Pasteur, Morocco
In collaboration: Univ Md V, Rabat
PHASE 1
State of art
PHASE 2
Platform
validation
PHASE 3
Laboratory
PHASE 4
Clinic
PHASE 5
Market
Development: MAScIR DIAGNOSTIC KITS
3 years
MEDICAL BIOTECHNOLOGY CENTRE
Products in development
Market oriented innovative & cost effective medical products:
- Molecular Diagnostic kits: Cancers, infectious diseases
- Biosimilar prototypes: anti-cancer biogenerics
ContextsIn African countries (except South Africa)
- All medical diagnostic kits & biogeneric medicines are imported
- A lot of patient samples are still sent to Europe for diagnostics
- These 2 procedures are time consuming & costly
Biochip testing Regular testing
MEDICAL BIOTECHNOLOGY CENTRE
ACHIEVMENTS (2010-2015)
2 diagnostic kits going to the market in 2016
2 other diagnostic kits going to the market in 2017
7 patents: 3 international
10 International Publications
Grant of 500 000 $ in 2014 from the Moroccan Government
Grant of 350 000 $ in 2015 from the Moroccan Government
Prize: l’OREAL France 2014 (10 000$)
Prize: Competitive Research Institution in Morocco in 2015 (10 000$)
Good Laboratory Practices (GLP), OHSSAS 1800, Prepare ISO17025
16
MASCIR MEDICAL BIOTECHNOLOGY-SOTHEMA Moroccan public-private partnership
Licensing kits to SOTHEMA
local pharmaceutical partner
Develop locally innovative & cost effective patented kits
- Local Market authorization- Marketing/distribution in
Morocco
Manufacturing Unit Morocco
MASCIR MEDICAL BIOTECHNOLOGY-SOTHEMA Example of Regional public-private partnership
Licensing kits to SOTHEMA
local pharmaceutical partner
Develop locally innovative & cost effective patented
diagnostic kits
Manufacturing Unit Senegal
Distribution in West AfricaCote D’Ivoire,Cameroun, Guinea…
Licensing kits to other Arab & African pharmaceutical
partners
Distribution in MENA & African
